A Dual-Action Therapeutic Composition from Solanum Aethiopicum for Integrated Management of Type 2 Diabetes and Obesity
Bibliographic record
Abstract
Background: Type 2 diabetes and obesity are tightly linked pandemics with shared pathophysiology and mounting global burden. Conventional pharmacotherapies frequently target single pathways and may worsen weight gain or fail to address composite metabolic risk. We developed YKD-001, a standardized therapeutic composition derived from Solanum aethiopicum L. (African eggplant) fruits, designed for simultaneous glycemic and weight control through multi-pathway actions. Methods: Fruits of S. aethiopicum were authenticated and processed via a proprietary hydroethanolic extraction and enrichment protocol that concentrates glycoalkaloids, steroidal alkaloids, and phenolic constituents. Phytochemical profiling used HPLC-DAD and LC–MS/MS against reference markers (e.g., solamargine, solasonine, chlorogenic acid, rutin). Bioactivity was evaluated in digestive enzyme assays (α-glucosidase, α-amylase, pancreatic lipase), cellular models of glucose uptake and insulin signaling (L6 myotubes and 3T3-L1 adipocytes), and diet-induced metabolic dysfunction in rodents. Safety was assessed by in vitro cytotoxicity and acute/subacute oral toxicity. Analyses employed ANOVA with post hoc tests. Results: The standardized extract yielded reproducible chemical fingerprints with batch-to-batch variation <10% for primary markers. YKD-001 inhibited α-glucosidase by 78%, α-amylase by 65%, and pancreatic lipase by 72% at standardized activity units, indicating concurrent attenuation of carbohydrate and lipid hydrolysis. In vivo, YKD-001 reduced fasting glucose by 35%, decreased HbA1c-equivalent markers by 28%, and produced 12% body weight loss versus baseline in obesediabetic rodent models. Cellular assays showed increased insulin-stimulated glucose uptake and enhanced AKT phosphorylation, with modest inhibition of adipogenesis and reduction in ROS. No acute toxicity was observed at limit doses; subacute administration showed no clinically meaningful changes in hematology, clinical chemistry, or histopathology. Conclusions: YKD-001 is a dual-action, multi-target composition that integrates enzyme inhibition, insulin sensitization, and antioxidant pathways to improve glycemic control and weight outcomes. These preclinical data support clinical evaluation of YKD-001 as a safe, standardized natural product candidate for metabolic syndrome, type 2 diabetes, and obesity.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.000 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.001 | 0.000 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.001 |
| Insufficient payload (model declined to judge) | 0.001 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".